NB
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
12.35
Exchange
XNAS - Nasdaq
-34 %
Last period Net income growth rate
-960%
Net income growth rate has decreased in 5 years
What is Net income growth rate ?
An indicator of the company's profit growth rate relative to the same periods of previous years.
See also Neurocrine
Company Analysis
NBIX valuation, rating, competitors, insights and company profile
Eyestock Rating
NBIX financial analysis by Eyestock methodology
Valuation
NBIX valuation using historical relative method
Statements
NBIX Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NBIX dividend yield and annual dividend
An indicator of the company's profit growth rate relative to the same periods of previous years.
Neurocrine`s Net income growth rate for the period ended 2024-06-30 is -34 %
